In children developing asthma, levels of the immune mediator IL-10 are lower than normal by the time these children are 6 years of age.

Pediatric heat-related illness emergency department volume is associated with higher temperatures and is increasing over time.

The 20-year cumulative incidence of keratinocyte carcinoma was 1.5% in those who survived childhood cancer, with most patients having several lesions.

Supplemental allergy patch testing in patients with suspected ACD revealed allergens not detected in standard screening.

For infants and young children hospitalized with RSV infection, ziresovir reduces signs and symptoms of bronchiolitis.

The Food and Administration (FDA) has approved Otulfi (ustekinumab-aauz), a biosimilar to Stelara® (ustekinumab).

The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.

Consensus recommendations have been established for pediatric mycosis fungoides, including additional clinical severity and outcome measures.

The United States government is offering another round of free COVID-19 tests, which will be available by the end of September.

Those who receive the COVID-19 vaccine during pregnancy are less likely to be hospitalized for COVID-19; however, vaccine uptake in this population is suboptimal.

Several minimally invasive injectable modalities are safe and effective for the management of hair loss in adults with androgenetic alopecia.

Extreme temperature-related deaths are projected to increase considerably by the mid-21st century in the contiguous United States.